Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IIV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Cambridge Cognition Holdings Plc

Cambridge Cognition provides technologies for assessing brain health, focusing on CNS clinical trials. Their platforms are used in-clinic or at home to enhance patient experiences and expedite drug development.

msh id	COM:CAMBRIDGECOGNITION
symbol	COG
name	Cambridge Cognition Holdings Plc
homepage url	https://www.cambridgecognition.com
country	GB
sector	Healthcare
industry	Medical - Healthcare Information Services
market	STOCKS
employee count	119
crunchbase url	-
linkedin url	-
founders	-

market cap	181.81K
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.3
growth cost of revenue	0.63
growth depreciation and amortization	-0.3
growth ebitda	-1.08
growth ebitda ratio	-1.07
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.23
growth gross profit	0.15
growth gross profit ratio	-0.08

COG

COM:CAMBRIDGECOGNITION

Cambridge Cognition

Last Close

27.70

21/11 11:20

Market Cap

140.30K

Beta: -

Volume Today

465

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	16.01M
cost of revenue	16.01M
depreciation and amortization	129.29K
ebitda	-43.93K
ebitda ratio	-0
eps	-0.02
eps diluted	-0.02
operating expenses	11.87M
operating income	-173.23K
operating income ratio	-0.01

accounts receivables	1.27M
capital expenditure	-237.25K
cash at beginning of period	8.55M
cash at end of period	10.45M
inventory	271.14K
working capital ttm	-1.56M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-